|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.740 USD | -5.01% |
|
-4.63% | -1.04% |
| 06-30 | Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) added to Russell 2000 Value-Defensive Index | CI |
| 06-30 | Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) added to Russell 2000 Defensive Index | CI |
Evolution of the Average Target: Vanda Pharmaceuticals Inc.
Evolution of the Target Price: Vanda Pharmaceuticals Inc.
Changes in Analyst Recommendations: Vanda Pharmaceuticals Inc.
bd5f1d9359e84d646.UDe_cbiVsoNsNIWANbkyoH3o7TarmtL2H2eG4UD8e04.JVXuPY75__A9AvHfRIpj4xSDtXP8qYO-aA7DsiG1DSFgZdIj3dbXt1lgtQ~2ffe898de3074d8bfe2a5ad277151dbd
More recommendations
| Consensus (Composite) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Ecart obj. / dr | ||
|---|---|---|---|---|---|---|
| +153.84% | ||||||
| +36.94% | ||||||
| +19.62% | ||||||
| +18.86% | ||||||
| +35.35% | ||||||
| +17.13% | ||||||
| +38.31% | ||||||
| +16.12% | ||||||
| -1.89% | ||||||
| +0.91% | ||||||
| Average | +33.52% | |||||
| Weighted average by Cap. | +22.86% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
4.990USD
Average target price
12.67USD
Spread / Average Target
+153.84%
High Price Target
20.00USD
Spread / Highest target
+300.80%
Low Price Target
5.000USD
Spread / Lowest Target
+0.20%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| HC Wainwright | |
| Jefferies & Co. | |
| BofA Securities | |
| Citigroup |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- VNDA Stock
- Consensus Vanda Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition